
1. mycoses. 2019 sep;62(9):835-846. doi: 10.1111/myc.12929. epub 2019 jun 9.

comparison fks gene mutations minimum inhibitory concentrations the
detection candida glabrata resistance micafungin: systematic review and
meta-analysis.

bienvenu al(1)(2)(3), leboucher g(1), picot s(2)(4).

author information: 
(1)groupement hospitalier nord, service pharmacie, hospices civils de lyon, lyon,
france.
(2)icbms cnrs 5246, smith, malaria research unit, université de lyon,
villeurbanne, france.
(3)groupement hospitalier nord, service hématologie, hospices civils de lyon,
lyon, france.
(4)groupement hospitalier nord, institut de parasitologie et mycologie médicale, 
hospices civils de lyon, lyon, france.

candida resistance antifungals impaired invasive candidiasis outcome. a
context echinocandin resistance development, aimed evaluate the
association phenotypic resistance micafungin fks mutations of
candida glabrata. systematic review meta-analysis, searched
medline, scopus web science reports published december 2017.
studies c glabrata candidiasis minimum inhibitory concentrations (mic)
determination micafungin fks genotyping included. reviews, studies
not using reference methods, non-glabrata candida, experimental isolates and
undetailed mutations excluded. two authors independently assessed the
eligibility articles extracted data. main outcome diagnostic
accuracy fks mutations compared micafungin mic c glabrata, measured 
fixed-effect odd ratio. heterogeneity calculated i2 statistic. 
study registered prospero (crd42018082023). twenty-four studies were
included meta-analysis. pooled analysis found s663p (or 7.25, 95% ci 
3.50-15.00; p < 0.00001), s629p (or 3.70, 1.64-8.33; p = 0.002) f659del (or
5.66, 1.22-26.18; p = 0.03) associated increased risk a
resistant isolate according authors' interpretation mics. sensitivity
analysis based new clsi clinical breakpoints, ors s663p s629p
remained significant. genotyping isolates c glabrata s663p s629p
mutations effective alternative micafungin susceptibility tests.
relevant molecular markers drug resistance significantly improve the
management c glabrata infections.

© 2019 blackwell verlag gmbh.

doi: 10.1111/myc.12929 
pmid: 31077631  [indexed medline]

